{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:34Z","timestamp":1753891834244,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Colorectal cancer (CRC) is one of the most common cancers worldwide. In the treatment of patients with CRC, oxaliplatin plays a pivotal role, with moderate side effects. Neurotoxicity, myelosuppression, ototoxicity, delayed hypersensitivity reactions, and rhabdomyolysis induced by oxaliplatin have been reported individually. However, the occurrence of oxaliplatin-induced ascites has not been reported previously. The objectives of this case report were to elaborate on the rare occurrence of ascites in a patient with CRC after oxaliplatin therapy and to explore its characteristics and causes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>We report on a case of upper rectal cancer seen in a 65-year-old man who underwent robotic-assisted laparoscopic anterior rectal resection. The patient developed ascites during postoperative adjuvant therapy with oxaliplatin and capecitabine. We ruled out tumor recurrence by laparoscopy, intraoperative biopsy, and biochemistry of the ascites. The patient did not experience a recurrence of ascites after discontinuation of chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case suggests that chemotherapy with oxaliplatin might cause ascites. The mechanism of the oxaliplatin-induced liver injury was further discussed, which might have been the cause of ascite formation. When patients with CRC who underwent chemotherapy with oxaliplatin develop ascites, surgeons should actively determine whether this is a side effect of chemotherapy or is due to tumor recurrence in order to avoid unnecessary surgery.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1372812","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T04:53:14Z","timestamp":1719463994000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The \u201cappearing\u201d and \u201cdisappearing\u201d ascites in the treatment of colorectal cancer: a case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Hong-Ming","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Peng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Ye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1470\u20132045(07)70281\u20134","article-title":"Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis","volume":"8","author":"Golfinopoulos","year":"2007","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/JCO.2012.42.5645","article-title":"Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial","volume":"30","author":"Tournigand","year":"2012","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0006\u20132952(03)00260\u20130","article-title":"DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells","volume":"66","author":"Faivre","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9266\u201321","article-title":"Oxaliplatin-related portal hypertension complicated with esophageal varices and refractory massive ascites","volume":"61","author":"Yazaki","year":"2022","journal-title":"Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231178685","article-title":"Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer","volume":"29","author":"Huang","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s10147\u2013020-01763\u20131","article-title":"Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan","volume":"25","author":"Ohta","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s12094\u2013019-02245\u20131","article-title":"Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)","volume":"22","author":"Saez-Carlin","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00432\u2013018-2691\u20138","article-title":"Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients","volume":"144","author":"Besora","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ejca.2010.10.006","article-title":"The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients","volume":"47","author":"Knijn","year":"2011","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clcc.2013.11.004","article-title":"Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers","volume":"13","author":"Zedan","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ajh.20516","article-title":"Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin","volume":"81","author":"Curtis","year":"2006","journal-title":"Am J Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/annonc\/mds074","article-title":"Oxaliplatin-related thrombocytopenia","volume":"23","author":"Jardim","year":"2012","journal-title":"Ann Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12029\u2013013-9489\u20133","article-title":"Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect","volume":"45","author":"Hijri","year":"2014","journal-title":"J Gastrointest Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1078155220970631","article-title":"Delayed hypersensitivity to oxaliplatin in a Nigerian patient with colorectal cancer-A case report","volume":"27","author":"Aliyu","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018\u2013228673","article-title":"Severe rhabdomyolysis related to oxaliplatin adjuvant therapy for colorectal cancer","volume":"12","author":"Pissarra","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/s0399\u20138320(06)73542\u20134","article-title":"Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy","volume":"30","author":"Arot\u00e7arena","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365\u20132559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s13304\u2013023-01630\u20134","article-title":"The aortic calcification is a risk factor for colorectal anastomotic leakage","volume":"75","author":"Liu","year":"2023","journal-title":"Updates Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12094\u2013023-03210\u20139","article-title":"The risk of postoperative complications is higher in stage I-III colorectal cancer patients with previous abdominal surgery: a propensity score matching analysis","volume":"25","author":"Liu","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152882","article-title":"Oxaliplatin-induced hepatic sinusoidal obstruction syndrome","volume":"460","author":"Zhu","year":"2021","journal-title":"Toxicology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL Clinical Practice Guidelines: Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2468\u20131253(19)30047\u20130","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000210025","article-title":"Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer","volume":"76","author":"Angitapalli","year":"2009","journal-title":"Oncology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"990","DOI":"10.4143\/crt.2015.296","article-title":"Splenomegaly and its associations with genetic polymorphisms and treatment outcome in colorectal cancer patients treated with adjuvant FOLFOX","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1372812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T04:53:17Z","timestamp":1719463997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1372812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":28,"alternative-id":["10.3389\/fonc.2024.1372812"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1372812","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"article-number":"1372812"}}